Literature DB >> 15672850

Etiology of community-acquired pneumonia treated in an ambulatory setting.

Thomas J Marrie1, Melanie Poulin-Costello, Michael D Beecroft, Zeljka Herman-Gnjidic.   

Abstract

BACKGROUND: Very few studies have addressed the etiology of community-acquired pneumonia (CAP) treated in an ambulatory setting.
METHODS: Patients were recruited from physicians' offices and from Emergency Rooms in Canada. Pneumonia was defined as two or more respiratory symptoms and signs and a new opacity on chest radiograph interpreted by a radiologist as pneumonia. Blood and sputum for culture as well as acute and convalescent serum samples for serology were obtained. Antibodies to Mycoplasma pneumoniae and Chlamydia pneumoniae were determined using enzyme-linked immunosorbent assays.
RESULTS: Five hundred and seven patients were enrolled in the study; 419 (82%) had blood cultures done, seven (1.4%) of which were positive for Streptococcus pneumoniae; 241 (47.5%) had a sputum processed for culture, 31% of which were positive for a potential respiratory pathogen. 437 (86.2%) had both acute and convalescent serum samples obtained, 148 (33.8%) of which gave a positive result. Overall an etiological diagnosis was made in 48.4% of the patients. M. pneumoniae accounted for 15% of the cases, C. pneumoniae 12%, S. pneumoniae 5.9% and Haemophilus influenzae 4.9%.
CONCLUSIONS: Despite considerable effort an etiological diagnosis of CAP treated on an ambulatory basis was made in only half the patients. The most commonly identified pathogens were M. pneumoniae, C. pneumoniae, S. pneumoniae,

Entities:  

Mesh:

Year:  2005        PMID: 15672850     DOI: 10.1016/j.rmed.2004.05.010

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  16 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.

Authors:  Laura Lawrence; Paul Danese; Joe DeVito; Francois Franceschi; Joyce Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

3.  Discrepant serological assays for Pneumococcus in renal transplant recipients - a prospective study.

Authors:  Jay A Fishman; David N Iklé; Robert A Wilkinson
Journal:  Transpl Int       Date:  2017-05-02       Impact factor: 3.782

4.  Increased lung cancer risk among patients with pneumococcal pneumonia: a nationwide population-based cohort study.

Authors:  Te-Yu Lin; Wen-Yen Huang; Jung-Chung Lin; Cheng-Li Lin; Fung-Chang Sung; Chia-Hung Kao; Jun-Jun Yeh
Journal:  Lung       Date:  2013-10-23       Impact factor: 2.584

Review 5.  Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.

Authors:  Christian Marchello; Ariella Perry Dale; Thuy Nhu Thai; Duk Soo Han; Mark H Ebell
Journal:  Ann Fam Med       Date:  2016-11       Impact factor: 5.166

6.  Effect of antimicrobial use on pneumococcal diagnostic tests in elderly patients with community-acquired pneumonia.

Authors:  A Saukkoriipi; A A Palmu; J Jokinen; V Verlant; W P Hausdorff; T M Kilpi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

Review 7.  [Contribution of microbiological investigations to the diagnosis of lower respiratory tract infections].

Authors:  O Leroy
Journal:  Med Mal Infect       Date:  2006-11-13       Impact factor: 2.152

8.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

9.  Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).

Authors:  Heike von Baum; Tobias Welte; Reinhard Marre; Norbert Suttorp; Christian Lück; Santiago Ewig
Journal:  BMC Infect Dis       Date:  2009-05-13       Impact factor: 3.090

Review 10.  Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia.

Authors:  Kay Wang; Peter Gill; Rafael Perera; Anne Thomson; David Mant; Anthony Harnden
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.